Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,037.5 | €1,089.7 | 5.033% |
| Eli Lilly Corp. | 75 | 0 | 13 | 0 | €817.90 | €831.01 | 1.603% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €435.75 | €459.90 | 5.542% |
| Medpace Holdings Inc | 17 | 0 | 1 | 0 | €319.00 | €418.12 | 31.073% |
| United Therapeutics | 28 | 1 | 3 | 0 | €310.40 | €315.21 | 1.549% |
| Amgen Inc. | 28 | 0 | 0 | 0 | €299.35 | €304.82 | 1.827% |
| Alnylam Pharmace. | 45 | 0 | 4 | 0 | €246.80 | €276.49 | 12.029% |
| Zoetis Inc. A | 22 | 1 | 1 | 0 | €176.08 | €198.11 | 12.512% |
| Johnson & Johnson | 41 | 1 | 4 | 0 | €150.74 | €194.53 | 29.051% |
| Krystal Biotech | 20 | 0 | 3 | 0 | €170.30 | €186.59 | 9.565% |
| AbbVie Inc. | 34 | 0 | 1 | 0 | €173.36 | €180.90 | 4.351% |
| Repligen Corp. | 14 | 0 | 0 | 0 | €122.70 | €180.11 | 46.789% |
| Neurocrine Bioscience | 42 | 0 | 5 | 0 | €110.05 | €155.89 | 41.654% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €106.40 | €126.38 | 18.778% |
| Ligand Pharmaceuticals | 1 | 0 | 1 | 0 | €91.50 | €120.00 | 31.148% |
| Abbott Laboratories | 19 | 0 | 1 | 0 | €106.28 | €116.25 | 9.379% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €63.46 | €100.74 | 58.743% |